HomeCompareLPUSF vs JNJ

LPUSF vs JNJ: Dividend Comparison 2026

LPUSF yields 4.14% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LPUSF wins by $7.9K in total portfolio value
10 years
LPUSF
LPUSF
● Live price
4.14%
Share price
$3.31
Annual div
$0.14
5Y div CAGR
16.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$38.3K
Annual income
$3,467.67
Full LPUSF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — LPUSF vs JNJ

📍 LPUSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLPUSFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LPUSF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LPUSF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LPUSF
Annual income on $10K today (after 15% tax)
$351.81/yr
After 10yr DRIP, annual income (after tax)
$2,947.52/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, JNJ beats the other by $1,089.88/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LPUSF + JNJ for your $10,000?

LPUSF: 50%JNJ: 50%
100% JNJ50/50100% LPUSF
Portfolio after 10yr
$34.4K
Annual income
$4,108.78/yr
Blended yield
11.94%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

LPUSF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
3.8
Piotroski
8/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LPUSF buys
0
JNJ buys
0
No recent congressional trades found for LPUSF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLPUSFJNJ
Forward yield4.14%2.14%
Annual dividend / share$0.14$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR16.8%28%
Portfolio after 10y$38.3K$30.5K
Annual income after 10y$3,467.67$4,749.88
Total dividends collected$15.2K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: LPUSF vs JNJ ($10,000, DRIP)

YearLPUSF PortfolioLPUSF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,183$483.43$10,594$274.49+$589.00LPUSF
2$12,556$590.16$11,294$360.69+$1.3KLPUSF
3$14,159$723.30$12,133$476.91+$2.0KLPUSF
4$16,040$890.30$13,156$635.42+$2.9KLPUSF
5$18,264$1,100.98$14,432$854.61+$3.8KLPUSF
6$20,911$1,368.43$16,056$1,162.76+$4.9KLPUSF
7$24,085$1,710.25$18,175$1,604.53+$5.9KLPUSF
8$27,921$2,150.26$21,009$2,252.68+$6.9KLPUSF
9$32,597$2,721.06$24,911$3,229.73+$7.7KLPUSF
10$38,346$3,467.67$30,458$4,749.88+$7.9KLPUSF

LPUSF vs JNJ: Complete Analysis 2026

LPUSFStock

Tyman plc supplies engineered fenestration components and access solutions to the construction industry. The company designs and manufactures products that enhance the comfort, sustainability, security, safety, and aesthetics of residential homes and commercial buildings. It operates through three divisions: Tyman North America, Tyman UK & Ireland, and Tyman International. The Tyman North America division manufactures window and door hardware components, extrusions, and sealing systems. It offers single and multipoint locking systems, decorative handle trim sets, and precision rollers; operators, tie bar/locks, and hinges for casement and awning applications; and locks/keepers, integrated tilt latches, rollers, balance systems, seals, and extruded profiles for hung and sliding window applications, as well as a range of specialty access and safety products, including smoke vents, roof access hatches, floor access doors, and ladder posts. The Tyman UK & Ireland division engages in the design, development, manufacture, and distribution of decorative and security hardware and smart ware for residential doors and windows under the ERA and Fab & Fix brands. It also distributes weather seals for residential and commercial fenestration applications, as well as Giesse branded aluminum hardware; and designs and supplies architectural door hardware for commercial applications, as well as offers manufacturing solution for roof, ceiling, wall, and floor access products to the commercial construction industry. The Tyman International division provides hardware and seals to the door and window industry. This segment provides its products under the Schlegel, Giesse, and Reguitti brands. The company was formerly known as Lupus Capital plc and changed its name to Tyman plc in February 2013. Tyman plc was incorporated in 1993 and is headquartered in London, the United Kingdom.

Full LPUSF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this LPUSF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LPUSF vs SCHDLPUSF vs JEPILPUSF vs OLPUSF vs KOLPUSF vs MAINLPUSF vs ABBVLPUSF vs MRKLPUSF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.